Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
ESMO Open
|
June 4, 2024
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis
E Palassini, G G Baldi, C M Ciniselli, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 19, 2019
Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers
M J L Mastboom, E L Staals, F G M Verspoor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
S Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
S Stacchiotti, M Saponara, R Frapolli, et al.
Oncogene
|
August 28, 2024
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
F Pantano, S Simonetti, M Iuliani, et al.
Scientific Reports
|
October 12, 2019
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
F G M Verspoor, M J L Mastboom, G Hannink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, S Stacchiotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2018
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, S Stacchiotti, et al.
ESMO Open
|
February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network
G G Baldi, A M Frezza, C Biagioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A Gronchi, S Stacchiotti, P Verderio, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
ESMO Open
|
June 4, 2024
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis
E Palassini, G G Baldi, C M Ciniselli, et al.
The Journal of Bone and Joint Surgery. American Volume
|
July 19, 2019
Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers
M J L Mastboom, E L Staals, F G M Verspoor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 2, 2014
Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
S Stacchiotti, M Tortoreto, G G Baldi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2017
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
S Stacchiotti, M Saponara, R Frapolli, et al.
Oncogene
|
August 28, 2024
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
F Pantano, S Simonetti, M Iuliani, et al.
Scientific Reports
|
October 12, 2019
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
F G M Verspoor, M J L Mastboom, G Hannink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, S Stacchiotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2018
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, S Stacchiotti, et al.
ESMO Open
|
February 6, 2026
Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network
G G Baldi, A M Frezza, C Biagioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 14, 2016
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
A Gronchi, S Stacchiotti, P Verderio, et al.
Page
of 7